You are visiting us from Virginia. You are located in HHS Region 3. Your Center is Central East ATTC.

Products and Resources Catalog

Center
Product Type
Target Audience
Language
Keywords
Date Range
Other
The New England ATTC in partnership with RICARES provided a basic/universal TA session titled “State-level homelessness and drug overdose mortality: Evidence from US panel data” on 3/21/24 from 12:30 PM to 1:30 PM. Although we in recovery science understand well that not having access to steady, safe, and secure housing is a risk factor for drug overdose for a given individual, less is known about the relationship between homelessness and overdose mortality (the rate of death resulting from drug overdose) at the state level. In this study, researchers looked at data on housing, population, substance use, overdose, unemployment, and other variables from 2007–2020 for all US states and Washington DC. The result was that overdose mortality was found to be positively associated with homelessness at the state level in other words, the more homelessness there is in a state, the higher the state’s overdose mortality rate is likely to be. However, they found that this association becomes weaker when fentanyl is widely available in a given state. Researchers concluded that, given this association, policies, and programs to prevent and reduce homelessness should be considered critical elements of overdose prevention efforts. Article link: www.sciencedirect.com/science/article/pii/S0376871623011481?ref=pdf_download&fr=RR-2&rr=85fb4e876ef442b5 Please find the meeting summary here: ATTC ReadingGroup 03212024 Summary
Published: March 22, 2024
Multimedia
    This webinar focuses on increasing knowledge among providers in the assessment and treatment of wounds as related to intravenous drug and xylazine use.     LEARNING OBJECTIVES: Explain opioid use disorder as a chronic illness. Increase level of comfort in the treatment and assessment of wound care as it relates to intravenous drug and Xylazine use. Share best practices for incorporating harm reduction philosophies and principles in the treatment of opioid use disorder (OUD).     TRAINERS:   Nicole Gastala, MD   Dr. Gastala is board certified in Family Medicine and Addiction Medicine. She graduated from Loyola Stritch School of Medicine and completed her Family Medicine residency at the University of Iowa. In her clinical role, she has developed and expanded MAR by mentoring new prescribers, precepting residents, and training clinicians within the Chicago and Illinois communities.  She has also focused on the development of a walk-in integrated behavioral health, addiction, and primary care program within her FQHC system. In January 2021, Dr Gastala joined the team at the Substance Use Prevention and Recovery Division of IDHS as the medical director.     Michael Huyck, NP   Michael Huyck is a Family Nurse Practitioner at the UIH Mile Square Health Center and adjunct clinical assistant professor with the University of Illinois College of Nursing. His clinical role at Mile Square is focused on integrative substance use disorder treatment and primary care. His clinical interests involve decreasing barriers to addiction care, piloting evidenced based interventions to address problems specific to populations with SUD, and training future nurses to care for those experiencing addiction. He provides a full range of SUD treatment including buprenorphine and methadone within his practice. His current projects include wound care and ultrasound guided phlebotomy for people who inject drugs.     The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.
Published: November 29, 2023
Multimedia
The risk of fatal overdose has changed significantly in recent years, most notably with the emergence of the illicit opioid fentanyl and the increasing prevalence of polypharmacy. In this webinar, presenters Michael Hite, MBA and Desislav Hite, MD discussed trends and patterns in overdose cases over the last 5 years, factors that can increase overdose risk including identifiable life events and mental health co-occurring conditions, and how different populations are affected across Region 10. They also discussed actionable interventions to enhance overdose safety including new medical devices and digital resources, harm reduction strategies, and collaboration with local community organizations. Download slides | View recording
Published: August 24, 2023
eNewsletter or Blog
May 2023 Dialogue – Addiction: Deadly Impact of Fentanyl | MHTTC: Mental Health Awareness Month | Prevention: SAMHSA’s National Prevention Week: Promoting Health and Wellness | ORN: Make Possibilities a Reality | Regional Spotlight: ORN Xylazine Regional Summit. Additional sections include behavioral health observances, virtual training and webinar events, Region 3 news, and new publications/resources. The Dialogue is designed to inform behavioral and mental health professionals of news and upcoming events in the HHS Region 3/Central East region. This electronic newsletter is disseminated bi-monthly on the first Tuesday. You are encouraged to provide us with any feedback or submit articles and topics for discussion in future issues of the newsletter, [email protected].   Sign up to receive the Dialogue and our weekly training bulletin in your mailbox.   Visit the Dialogue Archives.
Published: May 2, 2023
Multimedia
    DESCRIPTION: As the illicit opioid supply includes more and more fentanyl, there have been increasing concerns about increasing rates of buprenorphine initiation precipitating opioid withdrawal. This session will describe why we believe this is happening, how common it is, and buprenorphine initiation strategies to support patients in avoiding precipitated withdrawal.     LEARNING OBJECTIVES: Describe the challenges of buprenorphine initiation in the fentanyl era. Name three potential approaches to buprenorphine initiation. Counsel on reducing fentanyl-related harms.     TRAINER: Elizabeth Salisbury-Afshar, MD, MPH is an Associate Professor in the Departments of Family Medicine and Community Health and Population Health Sciences at the University of Wisconsin School of Medicine and Public Health in Madison, Wisconsin. She is the Program Director of the Preventive Medicine Residency and core Faculty for the Addiction Medicine Fellowship. Dr. Salisbury-Afshar is board certified in family medicine, preventive medicine/public health and addiction medicine and her expertise lies at the intersection of these fields. Her work has focused on expanding access to evidence-based substance use disorder treatment and harm reduction services. Past public health roles include serving as Medical Director of Behavioral Health Systems Baltimore, Medical Director at Heartland Alliance Health (a healthcare for the homeless provider in Chicago), and Medical Director of Behavioral Health at the Chicago Department of Public Health. Dr. Salisbury-Afshar received her Medical Degree from Rush University Medical College and her Master’s in Public Health from John Hopkins Bloomberg School of Public Health.     The Great Lakes A/MH/PTTC is offering this training for individuals working in HHS Region 5: IL, IN, MI, MN, OH, WI. This training is being provided in response to a need identified by Region 5 stakeholders.
Published: April 20, 2023
Print Media
This snapshot of information is intended to provide resources to individuals, parents, professionals, and providers on fentanyl use among Latinos in the United States. HOJA INFORMATIVA SOBRE EL FENTANILO PARA LOS PROVEEDORES Esta síntesis de información tiene por objeto proporcionar recursos a las personas, los padres, los profesionales y los proveedores sobre el consumo de fentanilo entre los Latinos en los Estados Unidos.
Published: March 30, 2023
Multimedia
Presenters: Sean Mahoney, Mental Health and Addiction Association of Oregon December 2022 It's one thing to believe in harm reduction but how do we actually have those conversations with people actively using substances? And what other things should we know about besides Narcan and clean needles? Peer and recovery mentor Sean Mahoney has been having these conversations for years and is excited to share his experience navigating these difficult conversations with safety, compassion and love. Mahoney has also seen how this conversation has changed over the years due to fentanyl, COVID and the emerging mental health crisis. Harm reduction for opioids and heroin for sure but also for meth, alcohol, benzos and beyond will be covered in this course as will the techniques and approaches to have a trauma informed conversation to let the people we serve know that their lives matter. Download slides | Watch recording
Published: December 15, 2022
Print Media
La falta de aceptación puede interferir con los atentos de ampliar el uso de tratamientos asistidos por medicamentos (TAM) para los trastornos por consumo de sustancias (TCS). Las Hojas Informativas de TAM ofrecen estrategias para generar apoyo para esta práctica basada en evidencia.  Hoja Informativa #1: Asegurando la Aceptación              Hoja Informativa #2: Reduciendo el Riesgo de Uso Indebido y la Desviación              Hoja Informativa #3: Abogando por las Medicamentos 
Published: September 14, 2022
Multimedia
Through the "One Pill Can Kill" campaign, the DEA is bringing awareness to the dangers of fentanyl, the threat of fake pills, and resources to keep people safe. The overarching goal was to provide participants with information about the "One Pill Can Kill" campaign and review a best practice communication strategy so participants felt confident in both their knowledge of the "One Pill Can Kill" campaign and in their ability to communicate it with others.   Learning Objectives Gain knowledge on the dangers of fentanyl Describe 3 key messages of the "One Pill Can Kill" awareness campaign Be familiar with resources to support the "One Pill Can Kill" campaign Review a best-practice communication strategy for sharing information Speakers Sean T. Fearns serves as the Chief of Community Outreach and Prevention Support for DEA since 2015.  In this capacity, Sean is responsible for guiding a diverse and creative staff to develop and implement strategic national partnerships with other organizations which help educate the public on the current drug threats facing the country, support the DEA field divisions, implement DEA’s Operation Engage, communicate key administration drug prevention messages, and help reduce the demand for those drugs.       Alex Waitt, MS, MSEd, LPC, is a licensed professional counselor and the Co-Project Director for the Central East ATTC where he is responsible for the programmatic and administrative coordination of all training and technical assistance for the CE ATTC Region. He is the spokesperson and liaison to stakeholders and supports the development of other training and workforce initiatives.           RESOURCES One Pill Can Kill DEA Campaign Webinar slides This webinar was provided by the Central East ATTC. The Central East ATTC is funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and managed by the Danya Institute.
Published: September 13, 2022
Multimedia
In partnership with Brown University SciToons and the Department of Emergency Medicine, the New England ATTC created the product "Opioid Overdose Rescue: 5 Ways to Save the Life." This educational video teaches the viewer how to recognize an overdose and how to effectively intervene. Watch the video to learn more. 
Published: September 1, 2022
Website
The Naloxone is an Act of Love website was developed with support by the New England Addiction Technology Transfer Center (ATTC) in partnership with the Center of Biomedical Research Excellence (COBRE) on Opioids and Overdose. The website hosts a suite of resources designed to reduce stigma surrounding the use of naloxone and those who experience an opioid overdose along with encouraging viewers to get trained in and carry Naloxone. Specific resources include narrative videos, posters, and coasters. 
Published: September 1, 2022
Print Media
Harm reduction is any action that reduces risk and increases personal and public safety. Harm reduction approaches have proven to prevent death, injury, disease, overdose, prevent substance misuse or disorder and most of us practice harm reduction techniques daily. For example, when we wear a seatbelt or apply sunscreen we are using harm reduction strategies.  Fentanyl strips, naloxone, and needle exchange programs are also examples of harm reduction.  This poster identifies some of the most common harm reduction methods in an attempt to normalize the term "harm reduction" and broaden the definition.   The Spanish translations were prepared by consultants for the Mountain Plains ATTC. While reasonable efforts are made to provide accurate translations, acknowledging the diversity of Spanish and English Language, some words/phrases may differ.   The poster can be downloaded in multiple formats directly from the MPATTC website. This product was designed for display as an 11x17 sized poster in a location most visible and accessible to behavioral health providers, educators, and/or peer recovery specialists but is also available in an 8.5x11 format for in-house printing. In addition, hard copies may be requested from the MPATTC by emailing us at [email protected] (posters can be mailed within the continental United States). Please click on the link below for more information.   To request an 11x17 "What is Harm Reduction?" poster to be mailed directly to you, please click "REQUEST A HARD COPY".  
Published: June 17, 2022
Multimedia
Sponsored by: California Department of Health Care Services (CA DHCS), Opioid and Stimulant Implementation Support-Training and Technical Assistance (OASIS-TTA)-MAT Expansion Project, UCLA Integrated Substance Abuse Programs (UCLA ISAP), Pacific Southwest Addiction Technology Transfer Center (PSATTC), HHS Region 9, & Opioid Response Network STR-TA   Course Description This session will address “The Fourth Wave” of the opioid epidemic, including recent data on rising mortality due to fentanyl alone and in combination with methamphetamine. The rise of polysubstance use, including the use of the so called “goofball,” has implications for morbidity and mortality and raises the complexity of treatment. Treatment options, including use of medications, will be discussed. The session will also cover harm reduction strategies including naloxone, drug surveillance, and drug checking. This session will also include training on how to use fentanyl test strips, as part of a comprehensive public health and harm reduction strategy. Fentanyl test strips are a practical and effective tool for people who use drugs as means to encourage overdose risk education and reduce risk of death. Training will include discussion on distribution, limitations, sourcing, messaging amongst other considerations in the application and administration of use. Launch Date: November 12, 2021   At the conclusion of the training, participants will be able to: 1. Recall the history, epidemiology and use patterns of two (2) drug classes, including synthetic opioids and stimulants. 2. Explain two (2) poly-drug use patterns involving synthetic opioids and methamphetamines and develop treatment strategies. 3. Propose three (3) harm reduction measures to prevent overdose deaths due to synthetic opioids. 4. Identify two (2) steps required when testing drug supply using Fentanyl Test Strips. CME Statements: The training course meets the qualifications for the provision of two (2.0) continuing medical education credits/contact hours (CMEs/CEHs). Continuing Education: The training course meets the qualifications for the provision of two (2.0) continuing education credits/contact hours (CEs/CEHs). Estimated time to complete the course: This course should take approximately 2 hours to complete. Cost: Free Disclosure statements: Dan Ciccarone, MD, MPH – University of California, San Francisco DISCLOSURES: Dr. Ciccarone is on the Scientific Advisory Board of Celero Systems and an expert witness in federal opioid litigation for Motley Rice LLC. All of the relevant financial relationships listed have been mitigated. Amanda Cowan, MS – CLARE|MATRIX DISCLOSURES: Reported no relevant financial relationships with commercial entities. Trainers: Dan Ciccarone, MD, MPH – University of California, San Francisco Amanda Cowan, MS – CLARE|MATRIX
Published: December 10, 2021
Multimedia
In this session, Larissa Mooney, MD, one of two PIs for the Greater Southern California Node of the NIDA Clinical Trials Network, discussed recent trends in co-occurring methamphetamine use and opioid use disorder (OUD), including overdose fatalities. Participants also learned about the treatment approaches to address this rising comorbidity. This webinar was sponsored by the Northwest and Pacific Southwest ATTCs and the Western States Node of the NIDA Clinical Trials Network. Download slides
Published: June 7, 2021
Print Media
This document is designed to reduce this information gap and help individuals and organizations better understand how the legal landscape in their state may impact access to harm reduction services and supplies, including overdose Good Samaritan laws, which provide limited protection from criminal sanctions to encourage people to call for help in an overdose emergency.
Published: February 24, 2021
Multimedia
Three-part webinar series offered by the Great Lakes ATTC and the Northwest ATTC. Part 1 of the series provides an overview of stimulant (cocaine and methamphetamine) use in the U.S. Presenter Rick Rawson, PhD will discuss: The extent and geography of stimulant use Clinical syndromes produced by acute and chronic stimulant use Strategies for addressing acute intoxication, withdrawal, and stimulant-induced psychosis Effective behavioral treatments for stimulant use disorders The status of pharmacotherapy research on treatments for stimulant use disorders A discussion of vulnerable populations, including the problem of stimulant use by individuals in medication treatment for opioid use disorder   PowerPoint Presentation  
Published: June 17, 2019
Interactive Resource
This one-hour, self-paced course on the HealtheKnowledge website is designed to equip peers and other outreach workers with information, resources, and practical tips to help them better understand opioids and their impact on individuals.  The course features four modules: Role of Peers in Recovery Opioids and the Brain Treatment Options Supporting Those Using Opioids Learn about effective treatment options and strategies for using person-centered care to engage people with opioid use disorder in their path to recovery. 1 NAADAC/NBCC CEU available!
Published: June 3, 2019
Print Media
Provides an overview of resources and initiatives to address opioid misuse in Illinois. Information effective May 2019.
Published: May 23, 2019

The ATTC Network understands that words have power. A few ATTC products developed prior to 2017 may contain language that does not reflect the ATTCs’ current commitment to using affirming, person-first language. We appreciate your patience as we work to gradually update older materials. For more information about the importance of non-stigmatizing language, see “Destroying Addiction Stigma Once and For All: It’s Time” from the ATTC Network and “Changing Language to Change Care: Stigma and Substance Use Disorders” from the Providers Clinical Support System (PCSS).

map-markermagnifiercrossmenuchevron-down